{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:03:20Z","timestamp":1749269000735,"version":"3.41.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007210","name":"Varian Medical Systems Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000040"],"award-info":[{"award-number":["UL1 TR000040"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijrobp.2025.03.037","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T10:18:48Z","timestamp":1743243528000},"page":"561-571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Timing of Planning Magnetic Resonance Imaging and Patient Selection for Adaptive Radiation Therapy in Newly Diagnosed High-Grade Glioma"],"prefix":"10.1016","volume":"122","author":[{"given":"Nicholas C.","family":"DeWalt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore K.","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Gallitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor J.","family":"Kinslow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Codruta","family":"Chiuzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanguang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gagandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey N.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony J.C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Grinband","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.03.037_bib0001","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: State of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0002","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/153303460400300308","article-title":"The impact of mid-treatment MRI on defining boost volumes in the radiation treatment of glioblastoma multiforme","volume":"3","author":"Manon","year":"2004","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0003","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4103\/0973-1482.19601","article-title":"T2 weighted MRI in assessment of volume changes during radiotherapy of high grade gliomas","volume":"1","author":"Shukla","year":"2005","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0004","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijrobp.2004.10.010","article-title":"Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies","volume":"62","author":"Tsien","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1748-717X-7-220","article-title":"Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in high-grade gliomas","volume":"7","author":"Champ","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0006","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2021.04.001","article-title":"Evolution of the gross tumour volume extent during radiotherapy for glioblastomas","volume":"160","author":"Bernchou","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0007","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ijrobp.2020.10.002","article-title":"Quantitating interfraction target dynamics during concurrent chemoradiation for glioblastoma: A prospective serial imaging study","volume":"109","author":"Stewart","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0008","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3346\/jkms.2013.28.8.1233","article-title":"Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma","volume":"28","author":"Kim","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0009","first-page":"3545","article-title":"Intensity-modulated radiotherapy for gliomas:dosimetric effects of changes in gross tumor volume on organs at risk and healthy brain tissue","volume":"9","author":"Yang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13014-022-02007-4","article-title":"A prospective comparison of adaptive and fixed boost plans in radiotherapy for glioblastoma","volume":"17","author":"Matsuyama","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3857\/roj.2021.00542","article-title":"Limited field adaptive radiotherapy for glioblastoma: Changes in target volume and organ at risk doses","volume":"40","author":"\u015eenkesen","year":"2022","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0012","first-page":"86","article-title":"Impact of volume of irradiation on survival and quality of life in glioblastoma: A prospective, phase 2, randomized comparison of RTOG and MDACC protocols","volume":"7","author":"Kumar","year":"2020","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1060098","article-title":"High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - Workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first report","volume":"12","author":"Tseng","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0014","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/neuonc\/noad258","article-title":"Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizon","volume":"26","author":"Tseng","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0015","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ijrobp.2024.08.016","article-title":"MR-linac on-line weekly adaptive radiotherapy for high grade glioma (HGG): Results from the UNITED single arm phase II trial","volume":"120","author":"Detsky","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0016","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.2147\/CMAR.S300094","article-title":"Study on the appropriate timing of postoperative adaptive radiotherapy for high-grade glioma","volume":"13","author":"Cao","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0017","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0018","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0019","first-page":"380","article-title":"Incidence and extent of disease progression on MRI between surgery and initiation of radiotherapy in glioblastoma patients","volume":"9","author":"Kraus","year":"2022","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0020","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.21873\/anticanres.14425","article-title":"Adaptive radiotherapy for glioblastoma multiforme - The impact on disease outcome","volume":"40","author":"V\u00e9gv\u00e1ry","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0021","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","article-title":"FSL","volume":"62","author":"Jenkinson","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109663","article-title":"ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma","volume":"184","author":"Niyazi","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0023","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11060-019-03152-9","article-title":"NRG brain tumor specialists consensus guidelines for glioblastoma contouring","volume":"143","author":"Kruser","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0024","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.3390\/cancers15102840","article-title":"Impact of postoperative changes in brain anatomy on target volume delineation for high-grade glioma","volume":"15","author":"Dejonckheere","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0025","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ijrobp.2024.03.036","article-title":"Predictors of tumor dynamics over a 6-week course of concurrent chemoradiotherapy for glioblastoma and the effect on survival","volume":"120","author":"Ong","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0026","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1038\/s41598-020-61701-z","article-title":"Optimal timing of radiotherapy following gross total or subtotal resection of glioblastoma: A real-world assessment using the National Cancer Database","volume":"10","author":"Buszek","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0027","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1038\/s41598-020-66608-3","article-title":"Survival impact of the time gap between surgery and chemo-radiotherapy in glioblastoma patients","volume":"10","author":"Zur","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0028","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1227\/NEU.0000000000001036","article-title":"Timing of adjuvant radiotherapy in glioblastoma patients: A single-institution experience with more than 400 patients","volume":"78","author":"Wang","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ijrobp.2025.03.037_bib0029","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11060-017-2587-5","article-title":"Volumetric quantification of glioblastoma: Experiences with different measurement techniques and impact on survival","volume":"135","author":"Henker","year":"2017","journal-title":"J Neurooncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162500269X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162500269X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T09:23:49Z","timestamp":1749201829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162500269X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S036030162500269X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.037","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timing of Planning Magnetic Resonance Imaging and Patient Selection for Adaptive Radiation Therapy in Newly Diagnosed High-Grade Glioma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}